title: Characterization of a potent uveitopathogenic site derived from rat phosducin.
abstract: Phosducin is a retinal and pineal phosphoprotein assumed to play an important role in visual phototransduction. Phosducin is also a uveitopathogenic retinal antigen, but its potency has been reported to be mild. During the course of studies aimed at identifying uveitopathogenic sites in phosducin, we found that rat phosducin possessed a potent uveitopathogenic site. In this study, we characterize the potent uveitopathogenic site by using synthetic peptides. Several synthetic peptides from this region plus adjuvants were injected into Lewis rats, and the uveitopathogenic core sequence was defined. We also determined the pivotal amino acid residues by using synthetic peptides with single residue substitution. Immunization with PDC(R)65-96 (amino acid residues 65 through 96 derived from rat phosducin) at doses of 0.83 nmol or more induced severe experimental autoimmune uveitis (EAU) in all rats within 12 days. Experimental autoimmune pinealitis (EAP) was also observed in all rats after immunization with 0.83 nmol or higher doses of the peptide. The lowest dose of the peptide to induce EAU and EAP was 0.24 nmol. The smallest peptide that induced EAU as severe as PDC(R)65-96 was PDC(R)77-87, which consisted of 11 amino acid residues (YELIHQDKEDE). The core sequence within the uveitopathogenic site was a pentapeptide (LIHQD), amino acid residues from 79 to 83. To determine the role of individual residues within PDC(R)77-87, we tested the uveitopathogenicity of analogues of PDC(R)75-85 and PDC(R)77-89, respectively, in which each of the residues from 77 to 87 was replaced by alanine (A). Analogous peptides bearing a single residue substitution at 80 (I-->A) and 82 (Q-->A), respectively, were not uveitopathogenic. Our findings demonstrated the presence of a potent uveitopathogenic site in PDC(R)65-96 whose potency in Lewis rats was comparable to that of S-antigen. The pivotal amino acid residues for uveitopathogenicity were the residues at 80 (I) and 82 (Q). The clinical and histological features of this EAU closely resembled those of the EAU induced by S-antigen and recoverin.
authors.affiliation: Department of Ophthalmology, Akita University School of Medicine, 1-1-1, Hondo, Akita City, 010, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Abe
authors.forename: N
authors.initials: N
authors.lastname: Satoh
authors.forename: A
authors.initials: A
authors.lastname: Nakajima
authors.forename: T
authors.initials: T
authors.lastname: Koizumi
authors.forename: M
authors.initials: M
authors.lastname: Tamada
authors.forename: S
authors.initials: S
authors.lastname: Sakuragi
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D005136:Eye Proteins / Q000009:adverse effects* / Q000737:chemistry / Q000276:immunology; D005260:Female; D020555:GTP-Binding Protein Regulators; D010446:Peptide Fragments / Q000276:immunology / Q000494:pharmacology; D010750:Phosphoproteins / Q000009:adverse effects* / Q000737:chemistry / Q000276:immunology; D010870:Pineal Gland; D051381:Rats; D011917:Rats, Inbred Lew; D014605:Uveitis / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology
chemical_list: D005136:Eye Proteins; D020555:GTP-Binding Protein Regulators; D010446:Peptide Fragments; D010750:Phosphoproteins; C065631:phosducin